Pesquisar
Stablecoin Development Ord Shs
SDEVAdicionar à lista de desejos
0.980USD
+0.083+9.25%
Fechamento 11-06 16:00（ET）
71.66MValor de mercado
0.10P/L TTM
Após o expediente 19:46 (ET)0.950USD-0.030-3.06%
Após o expediente 19:46 (ET)Sobre o Stablecoin Development Ord Shs Empresa
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
Stablecoin Development Ord Shs Perfil
Código da empresa- -
Nome da Empresa- -
Data de listagem- -
CEO- -
Número de funcionários- -
Tipo de títulos- -
Fim do ano fiscal- -
Endereço- -
Cidade- -
Bolsa de valores- -
País- -
Código postal- -
Telefone- -
Site- -
Código da empresa- -
Data de listagem- -
CEO- -
Executivos da empresa Stablecoin Development Ord Shs
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-100.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Henry Blynn
Mr. Henry Blynn
Chief Operating Officer
Chief Operating Officer
--
--
Mr. David Garcia Rios
Mr. David Garcia Rios
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
--
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
-100.00%
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Stablecoin Development Ord Shs?
Os cinco principais acionistas de Stablecoin Development Ord Shs são: Ms. Swan Sit
Quantas instituições possuem ações da Stablecoin Development Ord Shs (SDEV)?
Em 2026Q2, 41 instituições possuíam ações da Stablecoin Development Ord Shs, com valor de mercado aproximado de 1.42M, representando 5.34% do total de ações. Em comparação com 2026Q1, a participação institucional aumentou em 1112322.00.